8-KEarnings & ResultsExhibits & Filings

ABBOTT LABORATORIES 8-K Report, Financial Results (Apr 16, 2008)

Filed April 16, 2008For Securities:ABT

Summary

Abbott Laboratories (ABT) filed an 8-K on April 16, 2008, to report its first-quarter 2008 financial results. The report primarily furnishes a press release detailing these results, which were announced on April 15, 2008. Investors should note that Abbott utilizes non-GAAP financial measures, such as net earnings and diluted earnings per share excluding specified items, to provide a clearer view of ongoing business performance by adjusting for unusual or unpredictable factors like acquisition costs and R&D charges. The company's management believes these adjusted figures offer valuable insights for investors, allowing for a better evaluation of operational performance. However, the filing explicitly cautions investors to consider these non-GAAP measures alongside, and not as a replacement for, their GAAP-prepared financial statements. The primary exhibit referenced is the April 16, 2008 press release containing the detailed financial results.

Key Highlights

  • 1Abbott Laboratories announced its first-quarter 2008 financial results via an 8-K filing.
  • 2The filing includes a press release dated April 16, 2008, detailing the Q1 2008 performance.
  • 3Abbott employed non-GAAP financial measures, such as earnings per share excluding specified items, in its results announcement.
  • 4These non-GAAP measures are used to adjust for unusual or unpredictable factors, aiming to clarify ongoing business performance.
  • 5Examples of adjustments include acquisition-related costs, cost reduction initiatives, and R&D charges.
  • 6Management believes these adjusted measures provide useful insights for investors in evaluating business performance.
  • 7Investors are cautioned to consider these non-GAAP measures in conjunction with, not as a substitute for, GAAP financials.

Frequently Asked Questions

The primary purpose of this 8-K filing is to report Abbott Laboratories' financial results for the first quarter of 2008. It formally includes the press release that announced these results on April 16, 2008.

Non-GAAP financial measures are financial metrics that exclude or adjust for certain items that are not included in the most directly comparable GAAP (Generally Accepted Accounting Principles) measure. Abbott uses them to present net earnings and diluted earnings per share excluding specified items. Management believes these adjusted measures help investors better evaluate ongoing business performance by removing the impact of unusual or unpredictable factors like acquisition costs, restructuring charges, and certain R&D expenses.

No, Abbott explicitly cautions investors to consider these non-GAAP financial measures in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP. Investors should always review both GAAP and non-GAAP figures to get a complete picture.

The 8-K filing itself doesn't contain the detailed financial tables. Instead, it furnishes Exhibit 99.1, which is the press release dated April 16, 2008. This press release contains the actual first-quarter 2008 financial results, including the non-GAAP figures mentioned.